Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4740-4746, September 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, K.
Right arrow Articles by Shizume, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, K.
Right arrow Articles by Shizume, K.

Paraneoplastic Syndrome of Hypercalcemia and Leukocytosis Caused by Squamous Carcinoma Cells (T3M-1) Producing Parathyroid Hormone-related Protein, Interleukin 1{alpha}, and Granulocyte Colony-stimulating Factor1 ,2

Kanji Sato3, Yuko Fujii, Terutaka Kakiuchi, Keizo Kasono, Hidehito Imamura, Yukio Kondo, Hiroyuki Mano, Tetsuro Okabe, Shigetaka Asano, Fumimaro Takaku, Toshio Tsushima and Kazuo Shizume

Institute of Clinical Endocrinology, Tokyo Women's Medical College, Kawada-cho 8-1, Shinjuku-ku, Tokyo 162 [K. Sa., K. K., I. H., T. T., K. Sh.]; Research Institute of the Foundation for Growth Science in Japan [K. Sa., Y. F., T. T., K. Sh.], Shinjuku-ku, Tokyo; Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo [S. A., K. T.]; The Third Department of Internal Medicine, University of Tokyo [H. M., T. O., F. T.], Hongo, Bunkyo-ku, Tokyo; and The First Department of Internal Medicine, Medical Center of the Saitama Medical School [Y. K.], Saitama, Japan

Previously we reported that a clonal squamous cell carcinoma cell line (T3M-1) derived from a lower jaw cancer of a patient with marked leukocytosis and hypercalcemia produced factors containing a potent bone-resorbing activity (BRA) (Mr 15,000–20,000) and a colony-stimulating activity. To elucidate the pathogenesis of this humoral hypercalcemia, BRA and colony-stimulating activity in both the conditioned medium and cells were characterized.

The conditioned medium, when eluted at neutral pH, contained colony-stimulating activity and thymocyte proliferation-stimulating activity, the latter of which comigrated with BRA. Upon elution with acetic acid (pH 2.0), the conditioned medium contained no interleukin 1-like activity but potent parathyroid hormone-like activity, which comigrated with BRA. Northern blot hydridization analysis revealed that T3M-1 cells produced constitutively mRNA for parathyroid hormone-related protein and granulocyte colony-stimulating factor. Furthermore, primer extension analysis revealed that the cells also produced mRNA for interleukin 1{alpha}(IL-1{alpha}).

Since parathyroid hormone-related protein and IL-1{alpha} (osteoclast-activating factor) synergistically increase the concentration of serum calcium, and since IL-1{alpha} (hemopoietin 1) potentiates granulocyte colony-stimulating factor-induced granulocytopoiesis, we speculate that parathyroid hormone-related protein, granulocyte colony-stimulating factor, and IL-1{alpha} are synergistically involved in a paraneoplastic syndrome of hypercalcemia and leukocytosis, at least in some patients with solid tumors.

1 Part of this work was presented at the 59th Meeting of the Japan Endocrine Society, Nagasaki, October 1986; the IXth International Conference on Calcium-regulating Hormones and Bone Metabolism, Nice, France, October 1986; and at the 61st Meeting of the Japan Endocrine Society, July 1988.

2 This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (No. 61570563); a Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare, Japan (62-26); a research grant from the Foundation for Growth Science in Japan (especially donations from Toshiko Sato); a research grant for bone-regulating peptides from Chugai Pharmaceutical Co.; and the Kato Memorial Fund for Nambyou Research.

3 Recipient of "Morning Star Award" of the Japan Endocrine Society. To whom requests for reprints should be addressed.

Received 5/23/88. Revised 4/ 7/89. Accepted 5/17/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.